ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Phase of Trial: Phase IV
Latest Information Update: 02 Sep 2017
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- Acronyms ADAPT
- Sponsors United Therapeutics Corporation
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.
- 10 Jul 2017 Planned initiation date changed from 1 Jun 2017 to 1 Jul 2017.
- 10 Feb 2017 New trial record